{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:48:33Z","timestamp":1794001713879,"version":"4.8.0"},"reference-count":220,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.beem.2021.101484","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T15:22:09Z","timestamp":1610637729000},"page":"101484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression"],"prefix":"10.1016","volume":"35","author":[{"given":"C.M.","family":"Mosterd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.H.","family":"van den Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.H.","family":"van Raalte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rampanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10027","key":"10.1016\/j.beem.2021.101484_bib1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib2","first-page":"49","article-title":"Diabetic kidney disease: world wide difference of prevalence and risk factors","volume":"5","author":"Gheith","year":"2016","journal-title":"J Nephropharmacol"},{"issue":"20","key":"10.1016\/j.beem.2021.101484_bib3","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2215\/CJN.03350708","article-title":"Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D)","volume":"4","author":"Fried","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI clinical practice guideline for diabetes and CKD: 2012 update","volume":"60","author":"National Kidney","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in Type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.beem.2021.101484_bib7","first-page":"1093","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"374","author":"Rosenstein","year":"2016","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.beem.2021.101484_bib8","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.beem.2021.101484_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-8587(18)30141-4","article-title":"Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials","volume":"6","author":"Perkovic","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib10","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2337\/dc18-0588","article-title":"SGLT2 inhibitors in combination therapy: from mechanisms to clinical considerations in type 2 diabetes management","volume":"41","author":"van Baar","year":"2018","journal-title":"Diabetes Care"},{"issue":"22","key":"10.1016\/j.beem.2021.101484_bib11","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMc1713042","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Tonneijck","year":"2017","journal-title":"N Engl J Med"},{"issue":"10193","key":"10.1016\/j.beem.2021.101484_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(19)31150-X","article-title":"Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.beem.2021.101484_bib13","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1681\/ASN.2018040443","article-title":"The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): a randomized, controlled trial","volume":"29","author":"Saglimbene","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.beem.2021.101484_bib14","doi-asserted-by":"crossref","first-page":"2379432","DOI":"10.1155\/2017\/2379432","article-title":"Diabetic nephropathy: from pathophysiology to treatment","volume":"2017","author":"Shen","year":"2017","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009085","article-title":"Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults","volume":"5","author":"Larsen","year":"2010","journal-title":"PLoS One"},{"issue":"7122","key":"10.1016\/j.beem.2021.101484_bib17","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"issue":"7464","key":"10.1016\/j.beem.2021.101484_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Le Chatelier","year":"2013","journal-title":"Nature"},{"issue":"44","key":"10.1016\/j.beem.2021.101484_bib19","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"Backhed","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6150","key":"10.1016\/j.beem.2021.101484_bib20","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.beem.2021.101484_bib23","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00467-016-3527-x","article-title":"The gut-kidney axis","volume":"32","author":"Evenepoel","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib24","doi-asserted-by":"crossref","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","article-title":"Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets","volume":"312","author":"Pichler","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"10.1016\/j.beem.2021.101484_bib25","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.beem.2021.101484_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/ars.2016.6664","article-title":"Diabetes and kidney disease: role of oxidative stress","volume":"25","author":"Jha","year":"2016","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4093\/dmj.2017.0105","article-title":"The role of advanced glycation end products in diabetic vascular complications","volume":"42","author":"Rhee","year":"2018","journal-title":"Diabetes Metab J"},{"issue":"8 Suppl 3","key":"10.1016\/j.beem.2021.101484_bib28","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.ASN.0000077413.41276.17","article-title":"Role of advanced glycation end products in diabetic nephropathy","volume":"14","author":"Forbes","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.beem.2021.101484_bib29","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/ndt\/gfh207","article-title":"NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy","volume":"19","author":"Mezzano","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib30","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/db05-1554","article-title":"Diabetes-induced activation of canonical and noncanonical nuclear factor-kappaB pathways in renal cortex","volume":"55","author":"Starkey","year":"2006","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib31","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.etap.2015.01.019","article-title":"BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-kappaB pathway","volume":"39","author":"Kolati","year":"2015","journal-title":"Environ Toxicol Pharmacol"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/bcpt.12718","article-title":"Small molecule inhibiting nuclear factor-kB ameliorates oxidative stress and suppresses renal inflammation in early stage of alloxan-induced diabetic nephropathy in rat","volume":"120","author":"Borgohain","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"7","key":"10.1016\/j.beem.2021.101484_bib33","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00125-015-3596-6","article-title":"Peptide-based inhibition of IkappaB kinase\/nuclear factor-kappaB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes","volume":"58","author":"Oguiza","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2021.101484_bib34","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3389\/fimmu.2019.01223","article-title":"Interleukin-1beta inhibition for chronic kidney disease in obese mice with type 2 diabetes","volume":"10","author":"Lei","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1210\/en.2006-1300","article-title":"Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?","volume":"148","author":"Coughlan","year":"2007","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib36","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.2015.162","article-title":"Macrophage-derived tumor necrosis factor-alpha mediates diabetic renal injury","volume":"88","author":"Awad","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2021.101484_bib37","first-page":"1","article-title":"Tumor necrosis factor-a blockade ameliorates diabetic nephropathy in rats","author":"Dongsheng Cheng","year":"2019","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1523-1755.2004.00367.x","article-title":"Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury","volume":"65","author":"Chow","year":"2004","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-1797.2006.00576.x","article-title":"Macrophage accumulation in human progressive diabetic nephropathy","volume":"11","author":"Nguyen","year":"2006","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00125-006-0497-8","article-title":"Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db\/db mice","volume":"50","author":"Chow","year":"2007","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.beem.2021.101484_bib41","doi-asserted-by":"crossref","first-page":"F1719","DOI":"10.1152\/ajprenal.00141.2013","article-title":"Macrophages directly mediate diabetic renal injury","volume":"305","author":"You","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib42","doi-asserted-by":"crossref","first-page":"F1358","DOI":"10.1152\/ajprenal.00332.2011","article-title":"Monocyte\/macrophage chemokine receptor CCR2 mediates diabetic renal injury","volume":"301","author":"Awad","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib43","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1046\/j.1523-1755.1998.00911.x","article-title":"Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice","volume":"53","author":"Moore","year":"1998","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib44","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1681\/ASN.2004070612","article-title":"Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db\/db mice","volume":"16","author":"Chow","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00125-003-1253-y","article-title":"Juxtaglomerular apparatus T-cell infiltration affects glomerular structure in Type 1 diabetic patients","volume":"47","author":"Moriya","year":"2004","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diab.37.5.507","article-title":"Proteinuria and activated T-lymphocytes in diabetic nephropathy","volume":"37","author":"Bending","year":"1988","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib47","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1159\/000077594","article-title":"Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys","volume":"97","author":"Kikuchi","year":"2004","journal-title":"Nephron Exp Nephrol"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib48","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.178.6.2165","article-title":"Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling","volume":"178","author":"Imani","year":"1993","journal-title":"J Exp Med"},{"issue":"9-10","key":"10.1016\/j.beem.2021.101484_bib49","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.cca.2010.01.036","article-title":"Aberrant cytokines\/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy","volume":"411","author":"Wu","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib50","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1007\/s00125-010-1757-1","article-title":"Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury","volume":"53","author":"Lim","year":"2010","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.humimm.2014.02.007","article-title":"The alteration of Th1\/Th2\/Th17\/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy","volume":"75","author":"Zhang","year":"2014","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib52","first-page":"137","article-title":"Role of CD4+CD25+Foxp3+ regulatory T cells in type 2 diabetic nephropathy","volume":"29","author":"Xu","year":"2009","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"11","key":"10.1016\/j.beem.2021.101484_bib53","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.2337\/db11-0358","article-title":"Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy","volume":"60","author":"Eller","year":"2011","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib54","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41581-019-0234-4","article-title":"Innate immunity in diabetic kidney disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1681\/ASN.2010111210","article-title":"Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy","volume":"23","author":"Lin","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib56","doi-asserted-by":"crossref","first-page":"F143","DOI":"10.1152\/ajprenal.00398.2012","article-title":"The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules","volume":"305","author":"Mudaliar","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib57","doi-asserted-by":"crossref","first-page":"F1145","DOI":"10.1152\/ajprenal.00319.2012","article-title":"Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy","volume":"303","author":"Kaur","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib58","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/ki.2014.116","article-title":"Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria","volume":"86","author":"Verzola","year":"2014","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib59","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jdiacomp.2014.07.003","article-title":"Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy","volume":"28","author":"Jialal","year":"2014","journal-title":"J Diabetes Complications"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib60","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00125-012-2578-1","article-title":"Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice","volume":"55","author":"Kuwabara","year":"2012","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib61","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1210\/en.2012-2080","article-title":"Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice","volume":"154","author":"Cha","year":"2013","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib62","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/ATVBAHA.111.228924","article-title":"Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy","volume":"31","author":"Devaraj","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib63","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib64","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.kint.2017.05.034","article-title":"The hallmarks of mitochondrial dysfunction in chronic kidney disease","volume":"92","author":"Galvan","year":"2017","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072344","article-title":"Involvement of endoplasmic reticulum stress in albuminuria induced inflammasome activation in renal proximal tubular cells","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.beem.2021.101484_bib66","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2010020143","article-title":"The NLRP3 inflammasome promotes renal inflammation and contributes to CKD","volume":"21","author":"Vilaysane","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib67","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1681\/ASN.2015060676","article-title":"Caspase-1, but not Caspase-3, promotes diabetic nephropathy","volume":"27","author":"Shahzad","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.2014.271","article-title":"Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy","volume":"87","author":"Shahzad","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2021.101484_bib69","doi-asserted-by":"crossref","first-page":"504761","DOI":"10.1155\/2015\/504761","article-title":"NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia","volume":"2015","author":"Gao","year":"2015","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib70","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1038\/s41598-017-01994-9","article-title":"Metabolic injury-induced NLRP3 inflammasome activation dampens phospholipid degradation","volume":"7","author":"Rampanelli","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2021.101484_bib71","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2147\/DMSO.S199802","article-title":"A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation","volume":"12","author":"Zhang","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib72","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1042\/BST20190686","article-title":"Gut microbiota and metabolites in the pathogenesis of endocrine disease","volume":"48","author":"Fenneman","year":"2020","journal-title":"Biochem Soc Trans"},{"issue":"29","key":"10.1016\/j.beem.2021.101484_bib73","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib74","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut microbiota in health and disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib75","doi-asserted-by":"crossref","first-page":"a007294","DOI":"10.1101\/cshperspect.a007294","article-title":"Microbiota and autoimmunity","volume":"5","author":"Chervonsky","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.beem.2021.101484_bib76","doi-asserted-by":"crossref","first-page":"571731","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front Immunol"},{"issue":"6015","key":"10.1016\/j.beem.2021.101484_bib77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","article-title":"Induction of colonic regulatory T cells by indigenous Clostridium species","volume":"331","author":"Atarashi","year":"2011","journal-title":"Science"},{"issue":"5790","key":"10.1016\/j.beem.2021.101484_bib78","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1126\/science.1127119","article-title":"Symbiotic bacteria direct expression of an intestinal bactericidal lectin","volume":"313","author":"Cash","year":"2006","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib79","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.chom.2014.02.006","article-title":"Gut microbiota promote hematopoiesis to control bacterial infection","volume":"15","author":"Khosravi","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib80","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cell.2005.05.007","article-title":"An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system","volume":"122","author":"Mazmanian","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.beem.2021.101484_bib81","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1749-6632.1959.tb53104.x","article-title":"Morphological and physiological characterization of germfree life","volume":"78","author":"Gordon","year":"1959","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.beem.2021.101484_bib82","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.cell.2012.04.037","article-title":"Gut immune maturation depends on colonization with a host-specific microbiota","volume":"149","author":"Chung","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib83","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"issue":"7503","key":"10.1016\/j.beem.2021.101484_bib84","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nature13279","article-title":"Focused specificity of intestinal TH17 cells towards commensal bacterial antigens","volume":"510","author":"Yang","year":"2014","journal-title":"Nature"},{"issue":"7461","key":"10.1016\/j.beem.2021.101484_bib85","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.beem.2021.101484_bib86","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.4049\/jimmunol.1001443","article-title":"Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression","volume":"185","author":"Ochoa-Reparaz","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.beem.2021.101484_bib87","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1146\/annurev-immunol-042718-041841","article-title":"Gut microbiota regulation of t cells during inflammation and autoimmunity","volume":"37","author":"Brown","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"6032","key":"10.1016\/j.beem.2021.101484_bib88","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.1206095","article-title":"The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota","volume":"332","author":"Round","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib89","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chom.2012.08.004","article-title":"Outer membrane vesicles of a human commensal mediate immune regulation and disease protection","volume":"12","author":"Shen","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib90","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.immuni.2018.08.004","article-title":"Antibodies set boundaries limiting microbial metabolite penetration and the resultant mammalian host response","volume":"49","author":"Uchimura","year":"2018","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.beem.2021.101484_bib91","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"den Besten","year":"2013","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib92","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.beem.2021.101484_bib93","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"issue":"35","key":"10.1016\/j.beem.2021.101484_bib94","doi-asserted-by":"crossref","first-page":"56071","DOI":"10.18632\/oncotarget.11267","article-title":"Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice","volume":"7","author":"Hong","year":"2016","journal-title":"Oncotarget"},{"issue":"7268","key":"10.1016\/j.beem.2021.101484_bib95","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"issue":"7480","key":"10.1016\/j.beem.2021.101484_bib96","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib97","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nutres.2008.02.012","article-title":"Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells","volume":"28","author":"Usami","year":"2008","journal-title":"Nutr Res"},{"issue":"9","key":"10.1016\/j.beem.2021.101484_bib98","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jnutbio.2010.07.009","article-title":"Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils","volume":"22","author":"Vinolo","year":"2011","journal-title":"J Nutr Biochem"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib99","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.0009-9104.2002.01977.x","article-title":"Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages","volume":"130","author":"Millard","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib100","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1073\/pnas.1322269111","article-title":"The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition","volume":"111","author":"Chang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7480","key":"10.1016\/j.beem.2021.101484_bib101","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib102","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib103","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1681\/ASN.2014030288","article-title":"Gut bacteria products prevent AKI induced by ischemia-reperfusion","volume":"26","author":"Andrade-Oliveira","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.beem.2021.101484_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114881","article-title":"High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease","volume":"9","author":"Vaziri","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.beem.2021.101484_bib105","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1681\/ASN.2010121220","article-title":"Colonic contribution to uremic solutes","volume":"22","author":"Aronov","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061986","article-title":"Isolation and quantification of uremic toxin precursor-generating gut bacteria in chronic kidney disease patients","volume":"21","author":"Gryp","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib107","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000189334","article-title":"Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis","volume":"74","author":"Hida","year":"1996","journal-title":"Nephron"},{"issue":"32","key":"10.1016\/j.beem.2021.101484_bib108","doi-asserted-by":"crossref","first-page":"16105","DOI":"10.1073\/pnas.1821809116","article-title":"Remote sensing and signaling in kidney proximal tubules stimulates gut microbiome-derived organic anion secretion","volume":"116","author":"Jansen","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.beem.2021.101484_bib109","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s10482-016-0737-y","article-title":"A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression","volume":"109","author":"Jiang","year":"2016","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib110","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10060229","article-title":"Uremic toxins and clinical outcomes: the impact of kidney transplantation","volume":"10","author":"Liabeuf","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141738","article-title":"Serum Trimethylamine-N-Oxide is strongly related to renal function and predicts outcome in chronic kidney disease","volume":"11","author":"Missailidis","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib113","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41598-017-01387-y","article-title":"Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib114","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/AEM.05605-11","article-title":"Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients","volume":"78","author":"Wang","year":"2012","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ndt\/gfv353","article-title":"Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats","volume":"31","author":"Yoshifuji","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib116","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12882-020-01805-w","article-title":"The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature","volume":"21","author":"Stanford","year":"2020","journal-title":"BMC Nephrol"},{"issue":"7464","key":"10.1016\/j.beem.2021.101484_bib117","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature12480","article-title":"Dietary intervention impact on gut microbial gene richness","volume":"500","author":"Cotillard","year":"2013","journal-title":"Nature"},{"issue":"7228","key":"10.1016\/j.beem.2021.101484_bib118","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"issue":"7418","key":"10.1016\/j.beem.2021.101484_bib119","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"issue":"7452","key":"10.1016\/j.beem.2021.101484_bib120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib121","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2020.06.011","article-title":"The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study","volume":"32","author":"Wu","year":"2020","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19040995","article-title":"Gut microbiota and type 1 diabetes","volume":"19","author":"Han","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib123","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00592-019-01316-7","article-title":"Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition","volume":"56","author":"Tao","year":"2019","journal-title":"Acta Diabetol"},{"issue":"1P","key":"10.1016\/j.beem.2021.101484_bib124","first-page":"130","article-title":"Microbiota signatures in type-2 diabetic patients with chronic kidney disease - a pilot study","volume":"6P","author":"Gratiela","year":"2019","journal-title":"J Mind Med Sci"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mi.2016.75","article-title":"Mechanisms of inflammation-driven bacterial dysbiosis in the gut","volume":"10","author":"Zeng","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib126","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1681\/ASN.2019101029","article-title":"Dietary fiber protects against diabetic nephropathy through short-chain fatty acid-mediated activation of G protein-coupled receptors GPR43 and GPR109A","volume":"31","author":"Li","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.beem.2021.101484_bib127","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.3390\/toxins7103933","article-title":"Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis","volume":"7","author":"Deltombe","year":"2015","journal-title":"Toxins (Basel)"},{"issue":"11","key":"10.1016\/j.beem.2021.101484_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11110635","article-title":"Elevation of Trimethylamine-N-Oxide in chronic kidney disease: contribution of decreased glomerular filtration rate","volume":"11","author":"Pelletier","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib129","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.beem.2021.101484_bib130","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1136\/gutjnl-2018-317561","article-title":"Gut microbiota dynamics and uraemic toxins: one size does not fit all","volume":"68","author":"Joossens","year":"2019","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib131","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/MNH.0b013e328358c8d5","article-title":"CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity","volume":"21","author":"Vaziri","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7484","key":"10.1016\/j.beem.2021.101484_bib132","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib133","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1046\/j.1523-1755.2003.00314.x","article-title":"Evidence for impaired assimilation of protein in chronic renal failure","volume":"64","author":"Bammens","year":"2003","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/nu9050444","article-title":"Non-traditional aspects of renal diets: focus on fiber, alkali and vitamin K1 intake","volume":"9","author":"Cupisti","year":"2017","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.beem.2021.101484_bib135","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2217\/fmb.13.103","article-title":"Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients","volume":"8","author":"Mafra","year":"2013","journal-title":"Future Microbiol"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib136","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/ajcn\/80.6.1536","article-title":"Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept","volume":"80","author":"Bammens","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib137","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1053\/ajkd.2002.33407","article-title":"Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients","volume":"39","author":"Yasuda","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib138","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ndt\/gfq818","article-title":"The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression","volume":"26","author":"Meijers","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126048","article-title":"Free levels of selected organic solutes and cardiovascular morbidity and mortality in hemodialysis patients: results from the retained organic solutes and clinical outcomes (ROSCO) investigators","volume":"10","author":"Shafi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.beem.2021.101484_bib140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2369-14-134","article-title":"Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators","volume":"14","author":"Melamed","year":"2013","journal-title":"BMC Nephrol"},{"issue":"7","key":"10.1016\/j.beem.2021.101484_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132589","article-title":"Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib142","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.kint.2017.05.012","article-title":"Results of the HEMO study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes","volume":"92","author":"Shafi","year":"2017","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.beem.2021.101484_bib143","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","article-title":"Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib144","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41467-019-09735-4","article-title":"Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease","volume":"10","author":"Kikuchi","year":"2019","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.beem.2021.101484_bib145","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib146","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","article-title":"The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair","volume":"65","author":"Dou","year":"2004","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib147","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2215\/CJN.05340610","article-title":"Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress","volume":"6","author":"Yu","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib148","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","article-title":"The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells","volume":"5","author":"Dou","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib149","doi-asserted-by":"crossref","first-page":"C1201","DOI":"10.1152\/ajpcell.00471.2010","article-title":"NF-kappaB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells","volume":"301","author":"Shimizu","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.beem.2021.101484_bib150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2369-14-56","article-title":"Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-kappaB","volume":"14","author":"Bolati","year":"2013","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib151","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/gfs133","article-title":"p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells","volume":"28","author":"Sun","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib152","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5414\/CNP60161","article-title":"Association between blood indoxyl sulfate and carbonyl stress marker in hemodialysis patients","volume":"60","author":"Kato","year":"2003","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib153","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ Res"},{"issue":"39","key":"10.1016\/j.beem.2021.101484_bib154","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/eurheartj\/ehx342","article-title":"Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis","volume":"38","author":"Schiattarella","year":"2017","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.beem.2021.101484_bib155","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004947","article-title":"Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies","volume":"6","author":"Heianza","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib156","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bbrc.2017.09.108","article-title":"Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity","volume":"493","author":"Sun","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.beem.2021.101484_bib157","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.celrep.2017.05.077","article-title":"The TMAO-producing enzyme flavin-containing monooxygenase 3 regulates obesity and the beiging of white adipose tissue","volume":"19","author":"Schugar","year":"2017","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib158","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/gutjnl-2018-316155","article-title":"Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial","volume":"68","author":"Heianza","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib159","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1194\/jlr.M051680","article-title":"Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis","volume":"56","author":"Shih","year":"2015","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib160","doi-asserted-by":"crossref","first-page":"13781","DOI":"10.1038\/s41598-017-13739-9","article-title":"TMAO is associated with mortality: impact of modestly impaired renal function","volume":"7","author":"Gruppen","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib161","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ki.2011.355","article-title":"High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease","volume":"81","author":"Krishnamurthy","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2021.101484_bib162","first-page":"1","article-title":"Characterizing the gut microbiota in patients with chronic kidney disease","author":"Hu","year":"2020","journal-title":"Postgrad Med"},{"issue":"11","key":"10.1016\/j.beem.2021.101484_bib163","doi-asserted-by":"crossref","first-page":"11894","DOI":"10.1096\/fj.201901080R","article-title":"Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms","volume":"33","author":"Felizardo","year":"2019","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.beem.2021.101484_bib164","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092630","article-title":"Histone deacetylase inhibitors and diabetic kidney disease","volume":"19","author":"Hadden","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1-2","key":"10.1016\/j.beem.2021.101484_bib165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11010-012-1392-x","article-title":"The enhancement of phase 2 enzyme activities by sodium butyrate in normal intestinal epithelial cells is associated with Nrf2 and p53","volume":"370","author":"Yaku","year":"2012","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib166","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13105-017-0568-y","article-title":"Sodium butyrate protects against oxidative stress in HepG2 cells through modulating Nrf2 pathway and mitochondrial function","volume":"73","author":"Xing","year":"2016","journal-title":"J Physiol Biochem"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib167","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib168","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/JOE-16-0322","article-title":"Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC","volume":"232","author":"Dong","year":"2017","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib169","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-0042-121493","article-title":"Short-chain fatty acids inhibit oxidative stress and inflammation in mesangial cells induced by high glucose and lipopolysaccharide","volume":"125","author":"Huang","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib170","first-page":"3461","article-title":"Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease","volume":"18","author":"Salguero","year":"2019","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib171","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.arcmed.2014.04.002","article-title":"Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease","volume":"45","author":"Rossi","year":"2014","journal-title":"Arch Med Res"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345969","article-title":"Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am J Nephrol"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib173","first-page":"608","article-title":"Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases","volume":"80","author":"Vaziri","year":"1985","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.beem.2021.101484_bib174","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/gut.32.7.754","article-title":"Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure","volume":"32","author":"Magnusson","year":"1991","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib175","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2215\/CJN.03600807","article-title":"Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients","volume":"3","author":"Szeto","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib176","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.jrn.2011.05.004","article-title":"Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients","volume":"22","author":"Feroze","year":"2012","journal-title":"J Ren Nutr"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib177","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12882-020-01779-9","article-title":"Beta-glucans in advanced CKD: role in endotoxaemia and inflammation","volume":"21","author":"Wong","year":"2020","journal-title":"BMC Nephrol"},{"issue":"9","key":"10.1016\/j.beem.2021.101484_bib178","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2215\/CJN.03100315","article-title":"Associations of soluble CD14 and endotoxin with mortality, cardiovascular disease, and progression of kidney disease among patients with CKD","volume":"10","author":"Poesen","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib179","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1053\/j.ajkd.2009.06.022","article-title":"Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients","volume":"54","author":"Raj","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.beem.2021.101484_bib180","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/ndt\/gfr624","article-title":"Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation","volume":"27","author":"Vaziri","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib181","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1440-1797.2012.01647.x","article-title":"Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients","volume":"17","author":"Wang","year":"2012","journal-title":"Nephrology (Carlton)"},{"issue":"12","key":"10.1016\/j.beem.2021.101484_bib182","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10120520","article-title":"Association between protein-bound uremic toxins and asymptomatic cardiac dysfunction in patients with chronic kidney disease","volume":"10","author":"Chinnappa","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"11","key":"10.1016\/j.beem.2021.101484_bib183","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1517\/14728222.2013.829456","article-title":"Targeting protein-bound uremic toxins in chronic kidney disease","volume":"17","author":"Niwa","year":"2013","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib184","first-page":"481","article-title":"Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy","volume":"7","author":"Ma","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"36","key":"10.1016\/j.beem.2021.101484_bib185","doi-asserted-by":"crossref","first-page":"25101","DOI":"10.1074\/jbc.M114.578260","article-title":"NLRP3 inflammasome mediates albumin-induced renal tubular injury through impaired mitochondrial function","volume":"289","author":"Zhuang","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.beem.2021.101484_bib186","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.redox.2018.02.007","article-title":"Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: Antioxidant action of butyrate","volume":"16","author":"Yuan","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.beem.2021.101484_bib187","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fphys.2017.00350","article-title":"Elevated circulating trimethylamine N-oxide levels contribute to endothelial dysfunction in aged rats through vascular inflammation and oxidative stress","volume":"8","author":"Li","year":"2017","journal-title":"Front Physiol"},{"issue":"1-2","key":"10.1016\/j.beem.2021.101484_bib188","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2016.11.017","article-title":"Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome","volume":"481","author":"Sun","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.beem.2021.101484_bib189","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006347","article-title":"Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway","volume":"6","author":"Chen","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib190","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000484623","article-title":"Trimethylamine-N-oxide instigates NLRP3 inflammasome activation and endothelial dysfunction","volume":"44","author":"Boini","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.beem.2021.101484_bib191","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fphys.2017.00139","article-title":"Gut microbiota-dependent metabolite trimethylamine N-oxide contributes to cardiac dysfunction in western diet-induced obese mice","volume":"8","author":"Chen","year":"2017","journal-title":"Front Physiol"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib192","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lfs.2012.11.012","article-title":"Indoxyl sulfate upregulates renal expression of ICAM-1 via production of ROS and activation of NF-kappaB and p53 in proximal tubular cells","volume":"92","author":"Shimizu","year":"2013","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib193","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.beem.2021.101484_bib194","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114446","article-title":"p-Cresol affects reactive oxygen species generation, cell cycle arrest, cytotoxicity and inflammation\/atherosclerosis-related modulators production in endothelial cells and mononuclear cells","volume":"9","author":"Chang","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib195","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ndt\/gfl584","article-title":"P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production","volume":"22","author":"Schepers","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"50","key":"10.1016\/j.beem.2021.101484_bib196","doi-asserted-by":"crossref","first-page":"38869","DOI":"10.1074\/jbc.M110.166686","article-title":"Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin","volume":"285","author":"Ito","year":"2010","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.beem.2021.101484_bib197","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.chom.2016.10.021","article-title":"Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota","volume":"20","author":"Devlin","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.beem.2021.101484_bib198","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ejcn.2014.237","article-title":"Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials","volume":"69","author":"Chiavaroli","year":"2015","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib199","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1053\/j.jrn.2012.04.002","article-title":"Foods with added fiber lower serum creatinine levels in patients with chronic kidney disease","volume":"23","author":"Salmean","year":"2013","journal-title":"J Ren Nutr"},{"issue":"9","key":"10.1016\/j.beem.2021.101484_bib200","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.numecd.2015.03.015","article-title":"Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients","volume":"25","author":"Rossi","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib201","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/ajcn\/63.3.392","article-title":"Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a low-protein diet","volume":"63","author":"Bliss","year":"1996","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib202","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ndt\/gfp414","article-title":"p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin","volume":"25","author":"Meijers","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.beem.2021.101484_bib203","doi-asserted-by":"crossref","first-page":"568571","DOI":"10.1155\/2014\/568571","article-title":"Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients","volume":"2014","author":"Natarajan","year":"2014","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib204","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3345\/kjp.2013.56.4.159","article-title":"p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis","volume":"56","author":"Hyun","year":"2013","journal-title":"Korean J Pediatr"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2215\/CJN.05240515","article-title":"Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial","volume":"11","author":"Rossi","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib206","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/ndt\/gfq624","article-title":"Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study","volume":"26","author":"Nakabayashi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.beem.2021.101484_bib207","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12120741","article-title":"Effects of fecal microbiota transplantation on composition in mice with CKD","volume":"12","author":"Barba","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"3","key":"10.1016\/j.beem.2021.101484_bib208","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/gutjnl-2019-318320","article-title":"Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time","volume":"69","author":"de Groot","year":"2020","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.beem.2021.101484_bib209","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10090367","article-title":"Impacts of indoxyl sulfate and p-Cresol sulfate on chronic kidney disease and mitigating effects of AST-120","volume":"10","author":"Liu","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"3-4","key":"10.1016\/j.beem.2021.101484_bib210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000356370","article-title":"Cytotoxic effects of p-cresol in renal epithelial tubular cells","volume":"36","author":"Brocca","year":"2013","journal-title":"Blood Purif"},{"issue":"2","key":"10.1016\/j.beem.2021.101484_bib211","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/hdi.12483","article-title":"Indoxyl sulfate, a valuable biomarker in chronic kidney disease and dialysis","volume":"21","author":"Tan","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/j.beem.2021.101484_bib212","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.phrs.2019.01.019","article-title":"The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids","volume":"141","author":"Felizardo","year":"2019","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib213","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s13668-018-0248-8","article-title":"Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health","volume":"7","author":"Chambers","year":"2018","journal-title":"Curr Nutr Rep"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib214","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1038\/s41598-017-02989-2","article-title":"Alteration of the gut microbiota in Chinese population with chronic kidney disease","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.beem.2021.101484_bib215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12882-019-1668-4","article-title":"High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients","volume":"21","author":"Hu","year":"2020","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib216","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1515\/jccm-2017-0029","article-title":"Clinical features and outcomes of fusobacterium species infections in a ten-year follow-up","volume":"3","author":"Garcia-Carretero","year":"2017","journal-title":"J Crit Care Med (Targu Mures)"},{"issue":"4","key":"10.1016\/j.beem.2021.101484_bib217","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228530","article-title":"Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease","volume":"15","author":"Margiotta","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.beem.2021.101484_bib218","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000488947","article-title":"Dietary changes involving bifidobacterium longum and other nutrients delays chronic kidney disease progression","volume":"47","author":"Iwashita","year":"2018","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1016\/j.beem.2021.101484_bib219","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10070300","article-title":"Impact of altered intestinal microbiota on chronic kidney disease progression","volume":"10","author":"Castillo-Rodriguez","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"8","key":"10.1016\/j.beem.2021.101484_bib220","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s11255-018-1873-2","article-title":"The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus","volume":"50","author":"Kanbay","year":"2018","journal-title":"Int Urol Nephrol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:56:56Z","timestamp":1761497816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X21000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":220,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1521690X21000014"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2021.101484","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2021.101484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101484"}}